A 65-year-old patient with prostate adenocarcinoma was explored by 18F-fluorocholine (FCH) PET/CT for pretreatment staging because of a high risk of prostate cancer.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Images showed multiple foci with increased uptake of F-FCH within some pelvic and retroperitoneal lymph nodes, osseous foci (iliac bones and sacrum), and much more unusual, increased uptake foci within some left supraclavicular and left axillary lymph nodes. Owing to the rarity of spread to supraclavicular lymph nodes, surgical removal was performed and revealed prostate cancer metastases.
Pinaquy J, Allard J, Cornelis F, Pasticier G, De Clermont H. Are you the author?
Service de Médecine Nucléaire, Hôpital Pellegrin, CHU Bordeaux, Bordeaux; Service de Radiologie, Hôpital Pellegrin, CHU Bordeaux, Bordeaux; INCIA, UMR CNRS 5287, université Bordeaux Segalen, Bordeaux; Service d'urologie, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France.
Reference: Clin Nucl Med. 2015 Apr;40(4):e255-7.